The $535 million facility is the largest integrated neurology and neuroscience center in the U.S., and among the largest globally.
Five more notes:
1. The facility was designed to foster collaboration among researchers and physicians in neurology, neurosurgery and psychiatry.
2. It will “serve as a global destination for researchers to develop innovative treatments for intractable brain diseases,” according to an Oct. 28 news release.
3. UCSF Medical Center will leverage the Weill Neurosciences Building for neurological care. The facility’s clinical space is designed to serve up to 450 patients per day.
4. The facility will offer accelerated intake, consolidated diagnostic testing within one to two days, and multiple consultations with physicians.
5. The facility was made possible through a $185 million donation from Joan and Sanford Weill and the Weill Family Foundation in 2016.
“The UCSF Weill Neurosciences Building is a place for patients with the most complex and challenging cases to receive expert care, and a place for researchers to find answers to the most perplexing neurological and psychiatric conditions,” said Sam Hawgood, UC San Francisco chancellor. “The building’s design will enable us to bring researchers and clinicians together with our patients, to continue to advance that care into the future.”
To learn more, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
